The Effect of a Healthy Snack on Body Weight and Composition

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT03159689
Collaborator
(none)
131
1
2
34.9
3.8

Study Details

Study Description

Brief Summary

The results from this study may help to explain if incorporating mixed nuts in a reduced calorie diet will lead to weight loss.

Condition or Disease Intervention/Treatment Phase
  • Other: Mixed Tree Nuts
  • Other: Pretzels
N/A

Detailed Description

This study will compare two energy reduced diets; one diet will include one serving of mixed nuts (1.5oz) per day, while the other diet will include an equal amount of calories from a carbohydrate source, such as a pretzel snack. All subjects will receive a dietary plan that reduces their usual intake by 500kcal/day with the same percentage of fat, protein and carbohydrates for the first 12 weeks followed a diet with their usual intake for 12 weeks without nuts or pretzels.

Study Design

Study Type:
Interventional
Actual Enrollment :
131 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Clinical TrialRandomized Clinical Trial
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Mixed Nuts as Healthy Snack: Effect on Body Weight and Composition
Actual Study Start Date :
Feb 1, 2018
Actual Primary Completion Date :
Dec 30, 2020
Actual Study Completion Date :
Dec 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mixed Tree Nuts

a hypo caloric weight loss dietary plan with mixed tree nuts

Other: Mixed Tree Nuts
Individuals on a hypo caloric weight loss dietary plan supplemented with 1.5oz mixed tree nuts

Active Comparator: Pretzels

a hypo caloric weight loss dietary plan with pretzels

Other: Pretzels
Individuals on a hypo caloric weight loss dietary plan supplemented with 1.5oz pretzels

Outcome Measures

Primary Outcome Measures

  1. Change in body weight [baseline to Week 24]

    Weight loss as determined by body composition and body mass index

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female between the ages of 40-60 years of age (female premenopausal).

  • Body Mass Index (BMI) 27.0-35.0 kg/m2.

  • Not currently taking a prescription or over the counter medication for weight loss.

  • Not currently enrolled in any commercial weight loss program (e.g. Jenny Craig, Weight Watchers), internet based weight-management program, self-help group (e.g. Overeaters Anonymous) or participating in any food preparation/delivery program. If subject is willing to discontinue program immediately and willing to refrain from program for duration of study, he/she may be included after a two-week washout period.

  • Willing to keep and turn in a daily log/compliance book as required by study protocol.

  • Willingness and ability to make all scheduled appointments.

  • Willing to follow dietary recommendations required by study protocol.

  • Willingness to periodically have small blood samples drawn as indicated in the protocol.

Exclusion Criteria:
  • More than a 5-pound weight gain or weight loss within the 3 months prior to enrollment in the study.

  • History of thyroid disease, but not taking medication or medication dosage changed one or more times over last 6 months. History of thyroid disease and on a stable dose of prescription medication for 6 months or longer is acceptable.

  • History of Type I or Type II diabetes, major surgery, heart problems (e.g. angina, bypass surgery, MI, etc.), presence of implanted cardiac defibrillator or pacemaker, uncontrolled hypertension/high blood pressure, gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease, inflammatory bowel disease, fatty liver or cancer within three months of enrollment

  • History of a surgical procedure for weight loss at any time (e.g. gastroplasty, gastric by-pass, gastrectomy or partial gastrectomy).

  • Following a diet that requires the elimination of FODMAPS (Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols)

  • Following a specific diet that restricts specific food groups (eg. Paleo) or with extreme macronutrient ratios (carbohydrates, fats and proteins).

  • History of clinically diagnosed eating disorders including anorexia nervosa, bulimia nervosa or binge eating disorder.

  • Women who are pregnant, lactating or trying to become pregnant.

  • Currently taking any prescription medication for less than 3 months.

  • Currently taking any prescriptions drugs or supplements that may impact weight regulation

  • Currently consuming >14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and/or unwilling to limit intake to less than 3 drinks per week during study participation or history of alcohol dependency.

  • Known allergy to almond, pistachio, walnut, macadamia, cashews, hazelnuts, or pecan nuts.

  • Participation in another clinical trial within 30 days prior to enrollment.

  • Currently smoking cigarettes.

  • Any known clinically significant food allergy or intolerance.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCLA Center for Human Nutrition, 900 Veteran Avenue, WH 14-187 Los Angeles California United States 90095

Sponsors and Collaborators

  • University of California, Los Angeles

Investigators

  • Principal Investigator: Zhaoping Li, MD, PhD, UCLA Department of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhaoping Li, Principal Investigator, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT03159689
Other Study ID Numbers:
  • 17-000361
First Posted:
May 19, 2017
Last Update Posted:
Apr 19, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2021